DE69812094T2 - Feste, oral verabreichbare ribavirin dosisformen und verfahren zu deren herstellung - Google Patents

Feste, oral verabreichbare ribavirin dosisformen und verfahren zu deren herstellung

Info

Publication number
DE69812094T2
DE69812094T2 DE69812094T DE69812094T DE69812094T2 DE 69812094 T2 DE69812094 T2 DE 69812094T2 DE 69812094 T DE69812094 T DE 69812094T DE 69812094 T DE69812094 T DE 69812094T DE 69812094 T2 DE69812094 T2 DE 69812094T2
Authority
DE
Germany
Prior art keywords
ribavirin
composition
compacted
dosage form
orally administrable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69812094T
Other languages
German (de)
English (en)
Other versions
DE69812094D1 (de
Inventor
E. Bowen
A. Chaudry
M. Liebowitz
I. Stupak
A. Vadino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27130673&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69812094(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/997,169 external-priority patent/US5916594A/en
Priority claimed from US08/997,172 external-priority patent/US5914128A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of DE69812094D1 publication Critical patent/DE69812094D1/de
Application granted granted Critical
Publication of DE69812094T2 publication Critical patent/DE69812094T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69812094T 1997-12-22 1998-12-21 Feste, oral verabreichbare ribavirin dosisformen und verfahren zu deren herstellung Expired - Lifetime DE69812094T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/997,169 US5916594A (en) 1997-12-22 1997-12-22 Process of making solid ribavirin dosage forms
US08/997,172 US5914128A (en) 1997-12-22 1997-12-22 Orally administrable solid dosage form
PCT/US1998/026222 WO1999032128A1 (en) 1997-12-22 1998-12-21 Orally administrable solid ribavirin dosage forms and process for making them

Publications (2)

Publication Number Publication Date
DE69812094D1 DE69812094D1 (de) 2003-04-17
DE69812094T2 true DE69812094T2 (de) 2003-12-24

Family

ID=27130673

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69812094T Expired - Lifetime DE69812094T2 (de) 1997-12-22 1998-12-21 Feste, oral verabreichbare ribavirin dosisformen und verfahren zu deren herstellung

Country Status (26)

Country Link
US (3) US6337090B1 (enExample)
EP (2) EP0991415B1 (enExample)
JP (2) JP2001526234A (enExample)
KR (1) KR100575389B1 (enExample)
CN (1) CN1155388C (enExample)
AR (1) AR008977A1 (enExample)
AT (1) ATE234103T1 (enExample)
AU (1) AU762826B2 (enExample)
BR (1) BR9814367A (enExample)
CA (4) CA2365412C (enExample)
CO (1) CO4970774A1 (enExample)
DE (1) DE69812094T2 (enExample)
DK (1) DK0991415T3 (enExample)
ES (1) ES2191987T3 (enExample)
HU (1) HUP0100433A3 (enExample)
IL (1) IL136549A (enExample)
MY (1) MY119656A (enExample)
NO (1) NO20003234L (enExample)
NZ (1) NZ504994A (enExample)
PE (1) PE20000066A1 (enExample)
PL (1) PL190267B1 (enExample)
PT (1) PT991415E (enExample)
SK (1) SK284520B6 (enExample)
TW (1) TW575436B (enExample)
WO (1) WO1999032128A1 (enExample)
ZA (1) ZA9811726B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE234103T1 (de) * 1997-12-22 2003-03-15 Schering Corp Feste, oral verabreichbare ribavirin dosisformen und verfahren zu deren herstellung
US6793934B1 (en) * 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
EP1263341B1 (en) * 2000-03-06 2008-06-11 Salient Surgical Technologies, Inc. Fluid delivery system and controller for electrosurgical devices
US6720000B2 (en) * 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
KR20030020137A (ko) * 2001-09-03 2003-03-08 진양제약주식회사 리바비린 건조시럽제
RU2004116821A (ru) * 2001-11-02 2005-04-20 Сандоз Инк. (Us) Способ получения быстрорастворимой композиции с высоким содержанием рибавирина
DE10227148A1 (de) * 2002-06-18 2004-01-08 Biopartners Gmbh Verwendung von Ribavirin zur Herstellung einer pharmazeutischen Zusammensetzung gegen Bunyaviridae
US7538094B2 (en) * 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
US20040142903A1 (en) * 2003-01-16 2004-07-22 Par Pharmaceutical Inc. Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions
CN1980678A (zh) * 2003-03-28 2007-06-13 法莫赛特股份有限公司 治疗黄病毒感染的化合物
TR200701424T1 (tr) * 2004-09-09 2007-04-24 Bayer Healthcare Ag Suda çözünebilen katı dozaj formunda farmasötik bileşim.
US7723310B2 (en) * 2004-10-18 2010-05-25 Three Rivers Pharmaceuticals, Llc Large dose ribavirin formulations
US8062670B2 (en) * 2005-08-05 2011-11-22 3M Innovative Properties Company Compositions exhibiting improved flowability
EP2054076A2 (en) * 2006-08-21 2009-05-06 United Therapeutics Corporation Combination therapy for treatment of viral infections
WO2009142852A2 (en) * 2008-05-22 2009-11-26 3M Innovative Properties Company Process for manufacturing flowable powder drug compositions
WO2009158300A1 (en) * 2008-06-26 2009-12-30 3M Innovative Properties Company Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof
EP2309984B1 (en) * 2008-07-02 2018-04-11 3M Innovative Properties Company Method of making a dry powder pharmaceutical composition
EP2295037A1 (en) 2009-09-11 2011-03-16 Ratiopharm GmbH Pharmaceutical formulation containing Ribavirin
US10363453B2 (en) 2011-02-07 2019-07-30 New Balance Athletics, Inc. Systems and methods for monitoring athletic and physiological performance
CA2752008A1 (en) 2011-09-13 2013-03-13 Universite De Montreal Combination therapy using ribavirin as elf4e inhibitor
CN106389363A (zh) * 2016-10-18 2017-02-15 广东肇庆星湖生物科技股份有限公司 一种利巴韦林口服固体制剂及其制备方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3490742A (en) * 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
DE2735600A1 (de) * 1977-08-06 1979-02-15 Dynamit Nobel Ag Verfahren zur herstellung von phthalid
JPS57146593A (en) * 1981-03-09 1982-09-10 Ajinomoto Co Inc Preparation of ribofuranosyltriazole derivative
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4681765A (en) * 1984-09-13 1987-07-21 American Home Products Corporation Rapid releasing triamterene containing gelatin capsule dosage forms for once daily antihypertensive use
US5077279A (en) * 1986-05-01 1991-12-31 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
US5084445A (en) * 1986-05-01 1992-01-28 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
JPS63216820A (ja) * 1987-03-05 1988-09-09 Chugai Pharmaceut Co Ltd 抗ウイルス剤
GB8800276D0 (en) * 1988-01-07 1988-02-10 Univ Liverpool Medical treatment
US5030447A (en) * 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
US5192788A (en) * 1988-05-23 1993-03-09 Georgia State University Foundation, Inc. Porphyrin antiviral compositions
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
US5122517A (en) * 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
JP2908844B2 (ja) * 1990-06-29 1999-06-21 ヤマサ醤油株式会社 抗ウイルス剤
JPH07502740A (ja) * 1992-01-06 1995-03-23 ザ・ウエルカム・ファウンデーション・リミテッド 治療用ヌクレオシド
US5869097A (en) * 1992-11-02 1999-02-09 Alza Corporation Method of therapy comprising an osmotic caplet
US5358721A (en) * 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
JPH06298665A (ja) * 1993-04-14 1994-10-25 Toray Ind Inc 抗ウイルス剤
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
US5492692A (en) * 1993-08-17 1996-02-20 University Of Kentucky Research Foundation Coated products with potent anti-HIV and antimicrobial properties
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
CA2135669A1 (en) 1994-11-10 1996-05-11 Nils O. Johannesson Ribavirin as hepato (liver) protecting agent
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US6106865A (en) * 1995-01-09 2000-08-22 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
CA2213700C (en) * 1995-02-28 2002-04-02 Hoechst Marion Roussel, Inc. Pharmaceutical composition for piperidinoalkanol compounds
US6387365B1 (en) * 1995-05-19 2002-05-14 Schering Corporation Combination therapy for chronic hepatitis C infection
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US5723589A (en) * 1995-12-21 1998-03-03 Icn Pharmaceuticals Carbohydrate conjugated bio-active compounds
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
US6172046B1 (en) * 1997-09-21 2001-01-09 Schering Corporation Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
US5914128A (en) * 1997-12-22 1999-06-22 Schering Corporation Orally administrable solid dosage form
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms
ATE234103T1 (de) * 1997-12-22 2003-03-15 Schering Corp Feste, oral verabreichbare ribavirin dosisformen und verfahren zu deren herstellung

Also Published As

Publication number Publication date
NO20003234D0 (no) 2000-06-21
HUP0100433A3 (en) 2003-01-28
CA2323849C (en) 2002-06-11
AR008977A1 (es) 2000-03-08
US6051252A (en) 2000-04-18
CA2287056C (en) 2000-08-15
EP1321147A1 (en) 2003-06-25
KR20010033441A (ko) 2001-04-25
CN1155388C (zh) 2004-06-30
BR9814367A (pt) 2000-10-17
PL190267B1 (pl) 2005-11-30
AU762826B2 (en) 2003-07-03
DK0991415T3 (da) 2003-06-16
CA2365412C (en) 2002-09-17
CA2365412A1 (en) 1999-07-01
KR100575389B1 (ko) 2006-05-03
AU2199199A (en) 1999-07-12
DE69812094D1 (de) 2003-04-17
HUP0100433A2 (hu) 2001-12-28
ZA9811726B (en) 1999-06-21
ES2191987T3 (es) 2003-09-16
HK1034674A1 (en) 2001-11-02
ATE234103T1 (de) 2003-03-15
TW575436B (en) 2004-02-11
PT991415E (pt) 2003-06-30
CA2300452C (en) 2000-11-28
SK284520B6 (sk) 2005-05-05
IL136549A0 (en) 2001-06-14
US6337090B1 (en) 2002-01-08
JP2006083189A (ja) 2006-03-30
EP0991415A1 (en) 2000-04-12
PE20000066A1 (es) 2000-02-09
NO20003234L (no) 2000-08-21
MY119656A (en) 2005-06-30
CA2323849A1 (en) 1999-07-01
PL341230A1 (en) 2001-03-26
CO4970774A1 (es) 2000-11-07
JP2001526234A (ja) 2001-12-18
CA2287056A1 (en) 1999-07-01
NZ504994A (en) 2002-10-25
US6335032B1 (en) 2002-01-01
CA2300452A1 (en) 1999-07-01
EP0991415B1 (en) 2003-03-12
SK8942000A3 (en) 2001-04-09
WO1999032128A1 (en) 1999-07-01
IL136549A (en) 2005-05-17
CN1283117A (zh) 2001-02-07

Similar Documents

Publication Publication Date Title
DE69812094T2 (de) Feste, oral verabreichbare ribavirin dosisformen und verfahren zu deren herstellung
DE68903846T2 (de) Neue galenische form von fenofibrat.
DE69902893T2 (de) Schnellauflösende efavirenz-kapseln oder tabletten durch verwendung von super-zersetzern
DE69434479T2 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
DE69311395T2 (de) Sphäroidische Arzneimittelformulierung
DE69431247T2 (de) Oxybutyninformulierungen mit gesteuerter freisetzung
DE69110592T2 (de) Pharmazeutische Zubereitung mit verbessertem Geschmack, poröse Partikel enthaltend, und deren Herstellungsmethode.
EP2477660B1 (de) Pharmazeutische zusammensetzung mit den wirkstoffen metformin und sitagliptin oder vildagliptin
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
DE69108022T3 (de) Arzneimittel.
EP1509207B1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung
DE69217554T2 (de) Ebastin oder ebastin-analoga enthaltende arzneimittel
EP0275468B1 (de) Clodronat-haltige Arzneimittel und Verfahren zur Herstellung derselben
DE69730241T2 (de) Feste lösung eines fungizids mit erhöhter bioverfügbarkeit
AT396424B (de) Calcitoninsuppositorien
DE3936112C2 (de) Arzneimittelpräparate, die Piroxicam enthalten und Verfahren zu deren Herstellung
US5914128A (en) Orally administrable solid dosage form
DE69520292T2 (de) Pharmazeutische zubereitung zur direktverpressung
WO1998040085A1 (de) Stabile, feste zubereitung enthaltend vitamin d3 und tricalciumphosphat
DE69830997T2 (de) Pharmazeutische zusammensetzungen, die schwerlösliche arzneistoffe enthalten
DE2428639A1 (de) Therapeutische mittel
US5916594A (en) Process of making solid ribavirin dosage forms
DE69518035T2 (de) Abführmittel
AU742943B2 (en) Orally administrable solid ribavirin dosage forms and process for making them
EP0673913A1 (de) Calcium-Alkalicitratverbindungen und deren Verwendung als Arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition